Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 641023, 9 pages
http://dx.doi.org/10.1155/2015/641023
Research Article

The Diagnostic Ability of Follow-Up Imaging Biomarkers after Treatment of Glioblastoma in the Temozolomide Era: Implications from Proton MR Spectroscopy and Apparent Diffusion Coefficient Mapping

1Department of Diagnostic Imaging, Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic
2Department of Diagnostic Imaging, St. Anne’s University Hospital Brno, 656 91 Brno, Czech Republic
3International Clinical Research Center, St. Anne’s University Hospital Brno, 656 91 Brno, Czech Republic
4Department of Radiation Oncology, Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic
5Department of Radiation Oncology, Masaryk Memorial Cancer Institute, 656 53 Brno, Czech Republic
6Department of Neurosurgery, St. Anne’s University Hospital Brno, Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic
7Department of Neurosurgery, St. Anne’s University Hospital Brno, 656 91 Brno, Czech Republic

Received 23 January 2015; Revised 25 April 2015; Accepted 27 April 2015

Academic Editor: Murat Gokden

Copyright © 2015 Martin Bulik et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Martin Bulik, Tomas Kazda, Pavel Slampa, and Radim Jancalek, “The Diagnostic Ability of Follow-Up Imaging Biomarkers after Treatment of Glioblastoma in the Temozolomide Era: Implications from Proton MR Spectroscopy and Apparent Diffusion Coefficient Mapping,” BioMed Research International, vol. 2015, Article ID 641023, 9 pages, 2015. https://doi.org/10.1155/2015/641023.